It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?
The first drug shown to slow Alzheimer’s disease hit the U.S. market over a year ago, but sales have lagged, major hospital systems have taken months to start using it and some insurers have rejected coverage.
Doctors also expect some patients will hesitate to take Leqembi due to its limited impact and potential side effects. They say it will take years to learn how best to deploy the drug and that work must be done to improve diagnosis.
“This is the start of a very exciting journey,” said Dr. Ambar Kulshreshtha, a suburban Atlanta family physician focused on dementia patients.
More than 6 million Americans, and millions more worldwide, have Alzheimer’s disease, the most common cause of dementia. There’s no cure, but Leqembi clears a sticky brain protein called amyloid that’s a key indicator of Alzheimer’s.
Studies showed that it can delay the progression of the disease by a few months when given to people with mild symptoms. Some experts say the delay may be too subtle for patients to notice.
Related articles
Shooting injures 2 at Missouri high school graduation ceremony
CAPE GIRARDEAU, Mo. (AP) — Two people were injured when gunfire broke out during a high school gradu2024-05-21Researchers uncover future variations of irrigation water use in China
Researchers have developed a new method using machine learning and multiple data sets to estimate ir2024-05-21ECB leaves interest rates unchanged
FRANKFURT, April 11 (Xinhua) -- The European Central Bank (ECB) on Thursday decided to leave key int2024-05-21China to see more flights in summer
China's civil aviation transport will see steady growth in the summer-autumn aviation season thi2024-05-21Company wins court ruling to continue development of Michigan factory serving EV industry
GREEN TOWNSHIP, Mich. (AP) — A judge has ordered a Michigan community to stop blocking efforts to br2024-05-21S. Korea's opposition bloc wins three
SEOUL, April 11 (Xinhua) -- South Korea's liberal opposition bloc won more than three-fifths of seat2024-05-21
atest comment